Novo Nordisk A/S (NYSE:NVO)
$ 134.66 1.74 (1.31%) Market Cap: 599.89 Bil Enterprise Value: 602.45 Bil PE Ratio: 46.60 PB Ratio: 41.56 GF Score: 92/100

Novo Nordisk A/S Annual Shareholders Meeting Transcript

Mar 26, 2020 / 01:00PM GMT
Release Date Price: $28.38 (+7.05%)
Lars Fruergaard JÃ;rgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

¸ - /- -

Welcome to the Novo Nordisk Annual General Meeting. I would like to hand over the word to our Chairman of the Board, Helge Lund, who is participating on web stream live from Oslo. Helge?

Helge Lund;S;Independent Chairman of the Board
Novo Nordisk A

/-

Thank you, Lars. And good afternoon, and good morning to you all the Western Hemisphere, and welcome to the 2020 Annual General Meeting of Novo Nordisk. I'm pleased to welcome all shareholders to this meeting. I'm calling in from Novo Nordisk offices in Norway, and we'd like to start by thanking you all for making it possible for us to conduct the meeting even in this very unusual situation. The global crisis with coronavirus is impacting us all, privately as well as professionally. Each impacted country goes through the coronavirus at different stages and in different manners. We follow the situation closely and adhere to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot